These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 22188610)

  • 1. Chitosan hydrogels containing liposomes and cubosomes as particulate sustained release vaccine delivery systems.
    Gordon S; Young K; Wilson R; Rizwan S; Kemp R; Rades T; Hook S
    J Liposome Res; 2012 Sep; 22(3):193-204. PubMed ID: 22188610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of chitosan nanoparticles and chitosan hydrogels for vaccine delivery.
    Gordon S; Saupe A; McBurney W; Rades T; Hook S
    J Pharm Pharmacol; 2008 Dec; 60(12):1591-600. PubMed ID: 19000363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo investigation of twin-screw extruded lipid implants for vaccine delivery.
    Even MP; Young K; Winter G; Hook S; Engert J
    Eur J Pharm Biopharm; 2014 Jul; 87(2):338-46. PubMed ID: 24607791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo investigation of thermosensitive chitosan hydrogels containing silica nanoparticles for vaccine delivery.
    Gordon S; Teichmann E; Young K; Finnie K; Rades T; Hook S
    Eur J Pharm Sci; 2010 Oct; 41(2):360-8. PubMed ID: 20633644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modified thermoresponsive Poloxamer 407 and chitosan sol-gels as potential sustained-release vaccine delivery systems.
    Kojarunchitt T; Baldursdottir S; Dong YD; Boyd BJ; Rades T; Hook S
    Eur J Pharm Biopharm; 2015 Jan; 89():74-81. PubMed ID: 25481034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Administration routes affect the quality of immune responses: A cross-sectional evaluation of particulate antigen-delivery systems.
    Mohanan D; Slütter B; Henriksen-Lacey M; Jiskoot W; Bouwstra JA; Perrie Y; Kündig TM; Gander B; Johansen P
    J Control Release; 2010 Nov; 147(3):342-9. PubMed ID: 20727926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cubosomes containing the adjuvants imiquimod and monophosphoryl lipid A stimulate robust cellular and humoral immune responses.
    Rizwan SB; McBurney WT; Young K; Hanley T; Boyd BJ; Rades T; Hook S
    J Control Release; 2013 Jan; 165(1):16-21. PubMed ID: 23142776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunostimulatory biodegradable implants containing the adjuvant Quil-A--Part II: In vivo evaluation.
    Myschik J; McBurney WT; Hennessy T; Phipps-Green A; Rades T; Hook S
    J Drug Target; 2008 Apr; 16(3):224-32. PubMed ID: 18365884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunostimulatory lipid implants containing Quil-A and DC-cholesterol.
    Myschik J; McBurney WT; Rades T; Hook S
    Int J Pharm; 2008 Nov; 363(1-2):91-8. PubMed ID: 18692555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. pH Sensitive phosphorylated chitosan hydrogel as vaccine delivery system for intramuscular immunization.
    Wei J; Xue W; Yu X; Qiu X; Liu Z
    J Biomater Appl; 2017 May; 31(10):1358-1369. PubMed ID: 28387574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mono-N-carboxymethyl chitosan (MCC) and N-trimethyl chitosan (TMC) nanoparticles for non-invasive vaccine delivery.
    Sayin B; Somavarapu S; Li XW; Thanou M; Sesardic D; Alpar HO; Senel S
    Int J Pharm; 2008 Nov; 363(1-2):139-48. PubMed ID: 18662762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A protective vaccine delivery system for in vivo T cell stimulation using nanoengineered polymer hydrogel capsules.
    Sexton A; Whitney PG; Chong SF; Zelikin AN; Johnston AP; De Rose R; Brooks AG; Caruso F; Kent SJ
    ACS Nano; 2009 Nov; 3(11):3391-400. PubMed ID: 19824668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simple nanoliposomes encapsulating
    Bo R; Sun Y; Zhou S; Ou N; Gu P; Liu Z; Hu Y; Liu J; Wang D
    Int J Nanomedicine; 2017; 12():6289-6301. PubMed ID: 28894367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A cationic vaccine adjuvant based on a saturated quaternary ammonium lipid have different in vivo distribution kinetics and display a distinct CD4 T cell-inducing capacity compared to its unsaturated analog.
    Christensen D; Henriksen-Lacey M; Kamath AT; Lindenstrøm T; Korsholm KS; Christensen JP; Rochat AF; Lambert PH; Andersen P; Siegrist CA; Perrie Y; Agger EM
    J Control Release; 2012 Jun; 160(3):468-76. PubMed ID: 22709414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphatic-targeted cationic liposomes: a robust vaccine adjuvant for promoting long-term immunological memory.
    Wang C; Liu P; Zhuang Y; Li P; Jiang B; Pan H; Liu L; Cai L; Ma Y
    Vaccine; 2014 Sep; 32(42):5475-83. PubMed ID: 25110295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytosolic Delivery of Liposomal Vaccines by Means of the Concomitant Photosensitization of Phagosomes.
    Hjálmsdóttir Á; Bühler C; Vonwil V; Roveri M; Håkerud M; Wäckerle-Men Y; Gander B; Johansen P
    Mol Pharm; 2016 Feb; 13(2):320-9. PubMed ID: 26704885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting the allergen to oral dendritic cells with mucoadhesive chitosan particles enhances tolerance induction.
    Saint-Lu N; Tourdot S; Razafindratsita A; Mascarell L; Berjont N; Chabre H; Louise A; Van Overtvelt L; Moingeon P
    Allergy; 2009 Jul; 64(7):1003-13. PubMed ID: 19220212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity of lipid sustained release implants containing imiquimod, alpha-galactosylceramide, or Quil-A.
    Myschik J; McBurney WT; Hennessy T; Rades T; Hook S
    Pharmazie; 2008 Sep; 63(9):686-92. PubMed ID: 18819523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cationic polymer modified PLGA nanoparticles encapsulating Alhagi honey polysaccharides as a vaccine delivery system for ovalbumin to improve immune responses.
    Wusiman A; Gu P; Liu Z; Xu S; Zhang Y; Hu Y; Liu J; Wang D; Huang X
    Int J Nanomedicine; 2019; 14():3221-3234. PubMed ID: 31123399
    [No Abstract]   [Full Text] [Related]  

  • 20. Co-encapsulation of an antigen and CpG oligonucleotides into PLGA microparticles by TROMS technology.
    San Román B; Irache JM; Gómez S; Tsapis N; Gamazo C; Espuelas MS
    Eur J Pharm Biopharm; 2008 Sep; 70(1):98-108. PubMed ID: 18501572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.